World Health Organization Sounds Concern Over Acute Scarcity of Obesity Injections
Fewer than one in 10 people that would benefit from weight-loss injections like Wegovy have access to them, warns the WHO as it publishes its initial recommendations on the therapies.
Considering over a billion people worldwide now classified as obese, it is calling for more widespread and fairer availability to this class of drugs.
Per forecasts, over two billion could be living with obesity by 2030 without intervention.
"Our new guidance acknowledges that excess weight is a long-term condition that can be addressed with holistic and lifelong care," said WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and distribution challenges are major hurdles to widespread access to the jabs that can help people shift substantial weight, notes the organization.
Skinny Jab Supply Crisis
Even under the current most favorable scenario, the production of these medications might only reach approximately 100 million people – less than 10% of the global need, as stated by the health organization.
The advice encourages governments and firms to widen availability, by strategies such as patent sharing.
The intellectual property rights on a key compound – the main component of a leading brand – is scheduled to end in several nations in 2026.
The Way Weight-Loss Injections Operate
GLP-1 drugs replicate a biological compound to delay gastric emptying, reduce hunger and increase satiety so people reduce food intake.
People usually see weight reduction after several weeks of commencing the once-weekly jabs.
Studies points to users may put most of the weight back on a year later of discontinuing the drug, as their typical appetite return.
Being above a healthy weight raises your risk for developing medical conditions, including type 2 diabetes, heart disease, brain attack, and certain cancers.
Obesity impacts individuals in countries worldwide and was linked to over three and a half million deaths worldwide in 2024, as per the WHO.
